|
Pluristem Therapeutics
PSTI
|
$ 1.03 |
-1.9 % |
$ 33.3 M |
Nasdaq Global Select Market |
Israel |
|
Sorrento Therapeutics
SRNE
|
$ 0.27 |
-29.58 % |
$ 126 M |
Nasdaq Global Select Market |
USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
$ 3.79 |
-1.81 % |
$ 69.8 M |
Nasdaq Capital Market |
Israel |
|
Lyra Therapeutics
LYRA
|
$ 6.22 |
-4.75 % |
$ 310 M |
Nasdaq Global Market |
USA |
|
Caladrius Biosciences
CLBS
|
$ 0.43 |
-16.75 % |
$ 25.8 M |
Nasdaq Capital Market |
USA |
|
ContraFect Corporation
CFRX
|
$ 1.47 |
-5.16 % |
$ 5.39 M |
Nasdaq Capital Market |
USA |
|
Orchard Therapeutics plc
ORTX
|
$ 4.93 |
1.02 % |
$ 90.8 M |
Nasdaq Global Select Market |
Britain |
|
Moderna
MRNA
|
$ 106.56 |
-3.64 % |
$ 40.7 B |
Nasdaq Global Select Market,SPB |
USA |
|
NovaBay Pharmaceuticals
NBY
|
$ 0.1 |
-5.68 % |
$ 422 K |
NYSE American |
USA |
|
Heat Biologics, Inc.
HTBX
|
$ 3.93 |
-5.76 % |
$ 99.8 M |
Nasdaq Capital Market |
USA |
|
La Jolla Pharmaceutical Company
LJPC
|
$ 6.2 |
- |
$ 154 M |
Nasdaq Capital Market |
USA |
|
Zymeworks
ZYME
|
$ 6.42 |
- |
$ 404 M |
NYSE |
Canada |
|
Checkmate Pharmaceuticals
CMPI
|
$ 10.5 |
- |
$ 231 M |
Nasdaq Global Market |
USA |
|
Kadmon Holdings, Inc.
KDMN
|
$ 9.5 |
- |
$ 1.7 B |
Nasdaq Global Select Market |
USA |
|
CASI Pharmaceuticals
CASI
|
$ 3.61 |
20.33 % |
$ 491 M |
Nasdaq Capital Market |
USA |
|
PTC Therapeutics
PTCT
|
$ 29.09 |
-1.19 % |
$ 2.18 B |
Nasdaq Global Select Market,SPB |
USA |
|
AIkido Pharma
AIKI
|
$ 3.17 |
1.93 % |
$ 17.4 M |
Nasdaq Capital Market |
USA |
|
BioDelivery Sciences International
BDSI
|
$ 2.58 |
-4.8 % |
$ 255 M |
Nasdaq Global Select Market |
USA |
|
Protagonist Therapeutics
PTGX
|
$ 28.93 |
1.58 % |
$ 1.64 B |
Nasdaq Global Select Market |
USA |
|
Ardelyx
ARDX
|
$ 7.3 |
-1.48 % |
$ 1.6 B |
Nasdaq Global Market |
USA |